The Ensign Group (NASDAQ:ENSG) Posts Quarterly Earnings Results, Beats Estimates By $0.12 EPS

The Ensign Group (NASDAQ:ENSG) issued its quarterly earnings data on Monday. The company reported $1.92 earnings per share for the quarter, beating analysts’ consensus estimates of $1.80 by $0.12, FiscalAI reports. The Ensign Group had a net margin of 6.90% and a return on equity of 17.12%. The company had revenue of $1.44 billion for the quarter, compared to the consensus estimate of $1.44 billion. During the same quarter in the prior year, the firm earned $1.59 earnings per share. The firm’s revenue for the quarter was up 16.7% compared to the same quarter last year. The Ensign Group updated its FY 2026 guidance to 7.750-7.850 EPS.

The Ensign Group Trading Up 2.8%

Shares of NASDAQ:ENSG opened at $183.14 on Wednesday. The stock has a 50 day moving average of $165.47 and a 200 day moving average of $183.93. The company has a market cap of $10.70 billion, a PE ratio of 28.71, a price-to-earnings-growth ratio of 1.74 and a beta of 0.69. The Ensign Group has a 12-month low of $141.58 and a 12-month high of $218.00. The company has a current ratio of 1.56, a quick ratio of 1.56 and a debt-to-equity ratio of 0.06.

The Ensign Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Tuesday, June 30th will be given a dividend of $0.065 per share. This represents a $0.26 dividend on an annualized basis and a dividend yield of 0.1%. The ex-dividend date of this dividend is Tuesday, June 30th. The Ensign Group’s payout ratio is presently 4.08%.

The Ensign Group News Roundup

Here are the key news stories impacting The Ensign Group this week:

• Positive Sentiment: Q2 earnings beat expectations: Adjusted EPS was $1.92, exceeding the $1.80 consensus estimate and rising 20.8% year over year. GAAP diluted EPS increased 16.7% to $1.68, while revenue climbed 17.3% to $1.44 billion. The Ensign Group Reports Second Quarter 2026 Results
• Positive Sentiment: Guidance was raised: Ensign increased 2026 adjusted EPS guidance to $7.75–$7.85 from $7.48–$7.62 and revenue guidance to $5.87–$5.92 billion from $5.81–$5.86 billion. The new EPS midpoint is projected to grow 18.7% from 2025.
• Positive Sentiment: Operating trends remained favorable: Same-facility occupancy improved to 84.1%, skilled mix revenue increased 10.1%, and management cited clinical quality measures above peer averages and rehospitalization rates below the national average. Ensign also added 20 operations and reported $262.3 million in cash plus $591.6 million of available credit.
• Positive Sentiment: Analyst valuation support: The reported consensus price target is approximately $213.50, implying potential upside relative to recent trading levels. Consensus price target report
• Neutral Sentiment: Insider selling: Director John O. Agwunobi sold 392 shares for approximately $67,056 under a pre-arranged Rule 10b5-1 plan. The transaction reduced his holdings by 3.96%, but the planned nature of the sale limits its significance as a bearish signal.
• Negative Sentiment: Legal overhang persists: Rosen Law Firm and Kaplan Fox announced investigations into potential securities-law violations tied to allegations raised in a Hunterbrook short-seller report concerning staffing, care quality and financial disclosures. The claims remain allegations and could create litigation, regulatory and reputational risks. Kaplan Fox investigation
• Negative Sentiment: Acquisition execution risk: Newly acquired facilities have below-average occupancy and significant clinical and operational challenges, which could pressure margins if integration takes longer than expected.

Insider Buying and Selling

In other The Ensign Group news, Director Barry M. Smith sold 700 shares of the company’s stock in a transaction that occurred on Tuesday, June 2nd. The shares were sold at an average price of $164.28, for a total value of $114,996.00. Following the completion of the transaction, the director directly owned 21,352 shares in the company, valued at $3,507,706.56. This represents a 3.17% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director John O. Agwunobi sold 392 shares of the firm’s stock in a transaction on Monday, July 20th. The shares were sold at an average price of $171.06, for a total transaction of $67,055.52. Following the sale, the director owned 9,503 shares in the company, valued at $1,625,583.18. The trade was a 3.96% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last 90 days, insiders have sold 1,792 shares of company stock worth $309,599. 4.00% of the stock is owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. Wasatch Advisors LP raised its holdings in The Ensign Group by 6.0% during the second quarter. Wasatch Advisors LP now owns 3,558,675 shares of the company’s stock valued at $548,961,000 after acquiring an additional 199,983 shares during the period. Price T Rowe Associates Inc. MD boosted its stake in shares of The Ensign Group by 9.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 1,332,505 shares of the company’s stock worth $232,124,000 after acquiring an additional 118,110 shares during the period. Dimensional Fund Advisors LP grew its position in shares of The Ensign Group by 0.5% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,090,838 shares of the company’s stock worth $190,033,000 after purchasing an additional 5,458 shares in the last quarter. T. Rowe Price Investment Management Inc. grew its position in shares of The Ensign Group by 28.5% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 683,884 shares of the company’s stock worth $119,133,000 after purchasing an additional 151,792 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in The Ensign Group by 0.8% during the 3rd quarter. Franklin Resources Inc. now owns 522,691 shares of the company’s stock valued at $90,305,000 after purchasing an additional 4,206 shares during the period. Institutional investors own 96.12% of the company’s stock.

Analyst Ratings Changes

A number of equities research analysts have weighed in on the stock. Zacks Research lowered shares of The Ensign Group from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Wall Street Zen lowered The Ensign Group from a “buy” rating to a “hold” rating in a report on Saturday. Weiss Ratings cut The Ensign Group from a “buy (b)” rating to a “buy (b-)” rating in a research report on Tuesday, June 16th. Royal Bank Of Canada reissued an “outperform” rating and issued a $228.00 target price on shares of The Ensign Group in a research report on Tuesday. Finally, Truist Financial cut their price target on The Ensign Group from $215.00 to $202.00 and set a “hold” rating for the company in a research note on Tuesday, July 14th. Four equities research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $215.00.

About The Ensign Group

The Ensign Group, Inc is a diversified provider of post-acute healthcare services in the United States, operating a network of skilled nursing, assisted living, independent living, home health and hospice care centers. The company’s model emphasizes integrated care by employing multidisciplinary teams—including nursing staff, therapists and physicians—to deliver personalized rehabilitation and long-term care services for seniors and other patients recovering from injury, illness or surgery.

Through its owned and managed centers, The Ensign Group offers a broad spectrum of rehabilitation services such as physical, occupational and speech therapy.